Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysis
This systematic review and meta‐analysis aimed to compare the effectiveness and safety of
azvudine versus nirmatrelvir/ritonavir (Paxlovid) in treating coronavirus disease 2019 …
azvudine versus nirmatrelvir/ritonavir (Paxlovid) in treating coronavirus disease 2019 …
Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study
A Kapar, S Xie, Z Guo, Y Nan, Y Du, X Yin… - Expert Review of Anti …, 2024 - Taylor & Francis
Background Since the end of 2022, Azvudine was widely used to treat hospitalized novel
coronavirus disease 2019 (COVID-19) patients in China. However, data on the clinical …
coronavirus disease 2019 (COVID-19) patients in China. However, data on the clinical …